-
Invested Amount--
-
Wealth Gained--
-
Expected Amount--
Scheme Performance
1Y | 1Y | 3Y | 3Y | 5Y | 5Y | Max | Max | |
---|---|---|---|---|---|---|---|---|
Trailing Returns | 24.1% | 25.1% | 20.1% | 19.7% | ||||
Category Average | 33% | 30% | 22% | - |
Scheme Allocation
Holdings | Sector | Instrument | Asset |
---|---|---|---|
Cholaman.Inv.&Fn | Finance | Equity | 2.48% |
Federal Bank | Banks | Equity | 2.46% |
Tube Investments | Auto Ancillaries | Equity | 2.29% |
APL Apollo Tubes | Steel | Equity | 2.22% |
Bharat Forge | Castings, Forgings & Fastners | Equity | 2.13% |
Coforge | IT - Software | Equity | 2.12% |
Shriram Finance | Finance | Equity | 2.12% |
Polycab India | Cables | Equity | 2.06% |
Alkem Lab | Pharmaceuticals | Equity | 2.04% |
Astral | Plastic products | Equity | 2.03% |
Bharat Electron | Electronics | Equity | 1.99% |
Persistent Sys | IT - Software | Equity | 1.87% |
Jubilant Food. | Quick Service Restaurant | Equity | 1.86% |
Phoenix Mills | Realty | Equity | 1.84% |
J K Cements | Cement | Equity | 1.69% |
Max Financial | Finance | Equity | 1.64% |
Sundram Fasten. | Auto Ancillaries | Equity | 1.64% |
Ashok Leyland | Automobile | Equity | 1.63% |
Endurance Tech. | Auto Ancillaries | Equity | 1.58% |
Balkrishna Inds | Tyres | Equity | 1.55% |
P I Industries | Agro Chemicals | Equity | 1.54% |
Grindwell Norton | Capital Goods-Non Electrical Equipment | Equity | 1.52% |
Page Industries | Readymade Garments/ Apparells | Equity | 1.5% |
Syngene Intl. | Pharmaceuticals | Equity | 1.45% |
Dr Lal Pathlabs | Healthcare | Equity | 1.45% |
Motherson Wiring | Auto Ancillaries | Equity | 1.44% |
Schaeffler India | Bearings | Equity | 1.35% |
Kajaria Ceramics | Ceramic Products | Equity | 1.32% |
Mphasis | IT - Software | Equity | 1.23% |
Karur Vysya Bank | Banks | Equity | 1.21% |
Star Health Insu | Insurance | Equity | 1.21% |
ICICI Lombard | Insurance | Equity | 1.2% |
The Ramco Cement | Cement | Equity | 1.18% |
City Union Bank | Banks | Equity | 1.17% |
Coromandel Inter | Fertilizers | Equity | 1.16% |
CreditAcc. Gram. | Finance | Equity | 1.16% |
United Breweries | Alcoholic Beverages | Equity | 1.14% |
Crompton Gr. Con | Consumer Durables | Equity | 1.14% |
3M India | Diversified | Equity | 1.13% |
CIE Automotive | Castings, Forgings & Fastners | Equity | 1.11% |
Whirlpool India | Consumer Durables | Equity | 1.11% |
PB Fintech. | IT - Software | Equity | 1.1% |
L&T Technology | IT - Software | Equity | 1.09% |
Metro Brands | Leather | Equity | 1.07% |
Sundaram Finance | Finance | Equity | 1.04% |
Gujarat Gas | Gas Distribution | Equity | 1.01% |
Voltas | Consumer Durables | Equity | 0.99% |
Indian Bank | Banks | Equity | 0.99% |
Escorts Kubota | Automobile | Equity | 0.99% |
Apollo Hospitals | Healthcare | Equity | 0.97% |
La Opala RG | Glass & Glass Products | Equity | 0.96% |
Emami | FMCG | Equity | 0.96% |
NHPC Ltd | Power Generation & Distribution | Equity | 0.94% |
Muthoot Finance | Finance | Equity | 0.93% |
MTAR Technologie | Engineering | Equity | 0.92% |
Biocon | Pharmaceuticals | Equity | 0.92% |
LTIMindtree | IT - Software | Equity | 0.91% |
Volt.Transform. | Capital Goods - Electrical Equipment | Equity | 0.87% |
Oil India | Crude Oil & Natural Gas | Equity | 0.84% |
Honeywell Auto | Electronics | Equity | 0.82% |
Vedant Fashions | Retail | Equity | 0.72% |
J B Chem & Pharm | Pharmaceuticals | Equity | 0.7% |
V I P Inds. | Plastic products | Equity | 0.69% |
AAVAS Financiers | Finance | Equity | 0.69% |
Metropolis Healt | Healthcare | Equity | 0.67% |
Praj Industries | Capital Goods-Non Electrical Equipment | Equity | 0.65% |
Zydus Lifesci. | Pharmaceuticals | Equity | 0.62% |
PNC Infratech | Construction | Equity | 0.59% |
ERIS Lifescience | Pharmaceuticals | Equity | 0.58% |
Vardhman Textile | Textiles | Equity | 0.58% |
Team Lease Serv. | Miscellaneous | Equity | 0.57% |
Aarti Industries | Chemicals | Equity | 0.56% |
Narayana Hrudaya | Healthcare | Equity | 0.54% |
Prestige Estates | Realty | Equity | 0.54% |
Lupin | Pharmaceuticals | Equity | 0.51% |
IFB Industries | Consumer Durables | Equity | 0.47% |
MOIL | Mining & Mineral products | Equity | 0.45% |
SRF | Chemicals | Equity | 0.42% |
Pfizer | Pharmaceuticals | Equity | 0.34% |
360 ONE | Finance | Equity | 0.31% |
Laurus Labs | Pharmaceuticals | Equity | 0.28% |
Indian Hotels Co | Hotels & Restaurants | Equity | 0.2% |
Aarti Pharma | Pharmaceuticals | Equity | 0.12% |
Aditya AMC | Finance | Equity | 0.05% |
Del Dot Systems | Miscellaneous | Equity | 0% |
Sectors | Asset |
---|---|
Auto Components | 10.95% |
Industrial Products | 10.8% |
Finance | 8.33% |
Consumer Durables | 7.88% |
IT-Software | 6.2% |
Banks | 5.74% |
Healthcare Services | 5.19% |
Insurance | 3.85% |
Cash & Others | 3.39% |
Aerospace & Defense | 2.89% |
Cement & Cement Products | 2.69% |
Realty | 2.32% |
Leisure Services | 2.24% |
Textiles & Apparels | 2.17% |
Industrial Manufacturing | 1.65% |
Diversified | 1.52% |
IT-Services | 1.13% |
Beverages | 1.06% |
Electrical Equipments | 1.03% |
Gas | 1.01% |
Personal Products | 0.94% |
Power | 0.91% |
Retailing | 0.69% |
Construction | 0.59% |
Minerals & Mining | 0.46% |
Debt | 0.18% |
Capital Markets | 0.04% |
Others | 0.02% |
Advance Ratio
Exit Load
Exit Load | 1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment. |
---|
Fund Objective
The UTI-Mid Cap Fund is a diversified equity scheme launched on 7th April 2004 by UTI Mutual Fund.
The scheme distributes the majority of its investments across the financial services, capital goods, automobile and auto components, consumer durables, healthcare, IT, and chemicals sectors. It is managed by Ankit Agarwal.
The scheme’s investment objective is to achieve long-term capital appreciation by predominantly investing in equities and equity-related securities of mid-cap companies in India. The scheme aims to achieve its investment objective by investing in companies with scalable business models and substantial growth prospects.
The UTI-Mid Cap Fund invests at least 65% of its assets in mid-cap companies. Mid-cap companies are those which are ranked between 101st and 250th based on market capitalisation. The scheme has the flexibility to invest up to 35% of its assets in debt and money market instruments.
Pros & Cons
Pros |
Cons |
Since its inception, the UTI-Mid Cap Fund has delivered higher returns than its benchmark, the Nifty Midcap 150 TRI Index. | 3-year and 5-year annualised returns for this scheme are lower than the average for its category and its benchmark. |
The scheme has had a higher Sharpe ratio in the past 3 years compared to its category average, indicating that it has provided increased returns for each unit of additional risk. | In the past 3 years, the scheme has lagged behind its category average with a lower alpha, indicating underperformance. |
In the past 5 years, the Nifty Midcap 150 TRI Index’s price-to-earnings ratio has grown significantly compared to the Nifty 50 Index, indicating more significant long-term growth potential for mid-cap companies. | Over the past 3 years, UTI Mid-Cap Fund has shown higher volatility, with a higher standard deviation and beta than the average in its category. |
Who should invest in UTI-Mid Cap Fund?
The UTI Mid-Cap Fund is ideal for investors seeking capital growth and mid-cap stock exposure. The scheme implements a multi-stock investment strategy, diversifying holdings across over 60 stocks. Mid-cap stocks are often associated with a higher return potential than their large-cap counterparts and provide greater portfolio diversification benefits, making the UTI-Mid Cap Fund a suitable choice for investors considering these factors in their investment decisions.
The scheme is a well-regarded investment option in the Mid Cap category. The scheme has generated an average annual return of 18.3% since its inception. Its consistent performance, cost-effectiveness, and effective investment methodology have made it a sought-after investment choice among investors.
The UTI-Mid Cap Fund is ideal for investors with a 5-year or longer investment outlook and a very high tolerance for risk. However, if you prefer lower risk or a shorter investment horizon, other investment options may be more suitable for you than the UTI-Mid Cap Fund.
What are the benefits of investing in the UTI-Mid Cap Fund?
● The UTI-Mid Cap Fund has generated a CAGR of 18.3% since its inception, outperforming its benchmark, the Nifty Midcap 150 TRI Index.
● The scheme is open to investing in good companies undergoing short-term challenges or transformation and has the flexibility to stay invested in mid-cap companies that grow into large-cap status.
● The UTI-Mid Cap Fund prioritises companies with scalable business models and long-term growth potential, allowing investment opportunities in promising businesses.
● The scheme provides a balance between risk and growth potential, as it is less risky than small-cap funds and offers higher growth opportunities than large-cap funds.
● The UTI-Mid Cap Fund implements a “bottom-up stock selection” strategy. This method focuses on evaluating each company’s performance rather than being influenced by broader market trends or economic factors. This approach has the potential to generate higher returns for investors.
● It demonstrates better risk-adjusted performance than the category average, as indicated by higher Sharpe and Treynor ratios.
Fund Managers
Ankit Agarwal
After acquiring his B.Tech degree in computer science from the Indian Institute of Technology (IIT), Delhi, Mr. Ankit Agarwal went to the Indian Institute of Management(IIM) at Ahmedabad and subsequently earned a Master’s degree in Business Administration (MBA). With his strong education qualifications, he was hired by Deutsche Bank. He worked in credit trading for more than six years, initially as an associate and later as the vice president. He later worked at Bank of America as the Director and vice president, gaining immense experience in the banking segment. In December 2018, he co-founded Navi, a financial services company, and has since served as its CFO.
Risk-O-Meter
Peer Comparison
- Fund Name
- Fund Size
- 1Y
- 3Y Returns
- 5Y
-
Nippon India Growth Fund – Direct Growth- Equity .
- Mid Cap .
-
- 19,081
-
35.4%Fund Size - 19,081
-
32.2%Fund Size - 19,081
-
24.2%Fund Size - 19,081
-
SBI Magnum Midcap Fund – Direct Growth- Equity .
- Mid Cap .
-
- 13,202
-
27.5%Fund Size - 13,202
-
30.7%Fund Size - 13,202
-
23%Fund Size - 13,202
-
Kotak Emerging Equity Fund – Direct Growth- Equity .
- Mid Cap .
-
- 33,699
-
25.4%Fund Size - 33,699
-
28.2%Fund Size - 33,699
-
23.1%Fund Size - 33,699
-
Tata Mid Cap Growth Fund – Direct Growth- Equity .
- Mid Cap .
-
- 2,521
-
32.8%Fund Size - 2,521
-
27.1%Fund Size - 2,521
-
22.5%Fund Size - 2,521
-
Sundaram Mid Cap Fund – Direct Growth- Equity .
- Mid Cap .
-
- 8,477
-
30.4%Fund Size - 8,477
-
27%Fund Size - 8,477
-
17.8%Fund Size - 8,477
AMC Contact Details
Frequently Asked Questions
How to invest in UTI-Mid Cap Fund – Direct Growth ?
- Login to your 5paisa account, Go to the Mutual Funds section.
- Search for UTI-Mid Cap Fund – Direct Growth in the search box.
- Click on "Start SIP" if you wish to do a SIP or click on “One-time” if you wish to invest a lumpsum amount then click on "Invest Now"
What is the NAV of UTI-Mid Cap Fund – Direct Growth ?
How to redeem UTI-Mid Cap Fund – Direct Growth holding ?
What is the minimum sip amount of UTI-Mid Cap Fund – Direct Growth?
What are the top sectors UTI-Mid Cap Fund – Direct Growth has invested in?
- Auto Components - 10.95%
- Industrial Products - 10.8%
- Finance - 8.33%
- Consumer Durables - 7.88%
- IT-Software - 6.2%
Can I make investments in both the SIP and Lump Sum schemes of UTI-Mid Cap Fund – Direct Growth?
How much returns have UTI-Mid Cap Fund – Direct Growth generated ?
What is the expense ratio of UTI-Mid Cap Fund – Direct Growth ?
What is the AUM of UTI-Mid Cap Fund – Direct Growth?
What are the top stock holdings of UTI-Mid Cap Fund – Direct Growth?
- Cholaman.Inv.&Fn - 2.48%
- Federal Bank - 2.46%
- Tube Investments - 2.29%
- APL Apollo Tubes - 2.22%
- Bharat Forge - 2.13%
How can I redeem my investments in UTI-Mid Cap Fund – Direct Growth?
Step 2: Log in to your account by adding Folio No. and M-Pin
Step 3: Click on Widhrawal > Redemption
Step 4: Select UTI-Mid Cap Fund – Direct Growth in Scheme, enter the redemption amount, and click on submit button.
Is there any lock-in period for UTI-Mid Cap Fund - Direct Growth?
No, there is no lock-in period for UTI-Mid Cap Fund – Direct Growth.